Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
431. |
ECCT/08/08/03 | Partners PrEP Study Parallel Comparison of Tenofovir and Emtricitabine/Tenofovir Pre-exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples. |
Principal Investigator(s) 1. Prof. Connie Celum Site(s) in Kenya 1. Kenya- Eldoret (Uasin Gishu county) 2. Kenya – Nairobi (Nairobi City county) 3. Kenya – Kisumu (Kisumu county) 4. Kenya – Thika (Uasin Gishu county) |
View |
432. |
ECCT/08/06/01 | PARTNERS PrEP Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples |
Principal Investigator(s) 1. Elizabeth Anne Bukusi Site(s) in Kenya 1. Kisumu site (Kisumu county) |
View |
433. |
ECCT/20/09/04 | Pharmacy PrEP Delivery Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot Study |
Principal Investigator(s) 1. Prof. Elizabeth Bukusi Site(s) in Kenya 1. PHRDTHIKA (Kiambu county) 2. Kisumu Site (Kisumu county) |
View |
434. |
ECCT/23/10/05 | CAPTURE-2 Phase 2a Proof-of-Concept, Multicenter, Randomized, Open Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of a Single Dose of the Combination M5717-pyronaridine as Chemoprevention in Asymptomatic Adults and Adolescents with Plasmodium falciparum Malaria Infection. |
Principal Investigator(s) 1. Dr Lucas Otieno Tina Otieno Tina Site(s) in Kenya Victoria Biomedical Research Institute |
View |
435. |
ECCT/17/08/05 | Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection. Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection. |
Principal Investigator(s) 1. Isaac Tsikhutsu Site(s) in Kenya Kenya Medical Research Institute/Walter Reed Project HIV Program, Kericho |
View |